Krystal Biotech, Inc. (KRYS)
261.80
-0.87
(-0.33%)
USD |
NASDAQ |
Feb 20, 16:00
261.90
+0.10
(+0.04%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (Quarterly) : 41.45M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| DexCom, Inc. | 321.50M |
| Alkermes Plc | 171.77M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |